Technology | 2010.08.26
Medtronic Receives Health Canada Approval for the Newest Radiofrequency Ablation Tools for Atrial Fibrillation
MINNEAPOLIS & BRAMPTON, Ontario--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced it received Health Canada approval for the Medtronic Ablation Frontiers Cardiac Ablation System, a novel radiofrequency (RF) ablation technology for the treatment of atrial fibrillation (AF). AF is the most common heart arrhythmia that affects more than 250,000 Canadians1 and seven million people worldwide.2 The Medtronic Ablation Frontiers Cardiac Ablation System tools now approved for use in Canada in
For more information, please visit
http://www.businesswire.com/news/home/20100826005095/en
